CN102988543B - 一种治疗乳腺增生的中药及其制备方法 - Google Patents
一种治疗乳腺增生的中药及其制备方法 Download PDFInfo
- Publication number
- CN102988543B CN102988543B CN201210477093.8A CN201210477093A CN102988543B CN 102988543 B CN102988543 B CN 102988543B CN 201210477093 A CN201210477093 A CN 201210477093A CN 102988543 B CN102988543 B CN 102988543B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- vinegar
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 210000005075 mammary gland Anatomy 0.000 title abstract description 5
- 206010020718 hyperplasia Diseases 0.000 title abstract description 4
- 239000000052 vinegar Substances 0.000 claims abstract description 26
- 235000021419 vinegar Nutrition 0.000 claims abstract description 26
- 239000004863 Frankincense Substances 0.000 claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 14
- 241001057584 Myrrha Species 0.000 claims description 12
- 241000195474 Sargassum Species 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 241000545442 Radix Species 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 2
- 210000000481 breast Anatomy 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 3
- 240000007311 Commiphora myrrha Species 0.000 abstract description 2
- 208000019255 Menstrual disease Diseases 0.000 abstract description 2
- 210000001124 body fluid Anatomy 0.000 abstract description 2
- 239000010839 body fluid Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 241001474374 Blennius Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 238000009499 grossing Methods 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- -1 Herba Taraxaci Substances 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001608538 Boswellia Species 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000013228 adenopathy Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗乳腺增生的中药及其制备方法。本发明的中药各组成的重量份为:生牡蛎10-30份、丹参10-30份、海藻10-30份、黄芪10-30份、蒲公英5-15份、醋乳香1-5份、醋没药1-5份、炒王不留行1-5份、青皮1-5份和人工麝香0.005-0.02份。该中药的制备方法为将上述原料药物混合粉碎,制成散剂,装瓶即可。本发明的中药具有疏肝理气、软坚散结、活血化瘀、益气生津、通络止痛的作用。用于治疗乳腺增生,同时可调整月经紊乱,促进乳房健美,并且使用方便,价格便宜。
Description
技术领域
本发明涉及医药领域,具体涉及一种治疗乳腺增生的中药及其制备方法。
背景技术
乳腺增生是指乳腺上皮和纤维组织增生,乳腺组织导管和乳腺小叶在结构上的退行性病变及进行性结缔组织的生长,其发病原因主要是由于内分泌激素失调。据调查显示有70~85%的成年女性有不同程度的乳腺增生。据最新调查显示乳腺增生已成为女性最常见的乳腺疾病问题,不仅发病率逐渐上升,而且发病人群越来越低龄化。
治疗乳腺增生病的药物有很多,但大多为口服给药,服用剂量大,用药周期长,给患者带来的经济负担大。
发明内容
针对上述存在的问题,本发明的目的在于提供一种用于治疗乳腺增生的中药。
本发明的技术方案是一种用于治疗乳腺增生的中药各组成重量份为:生牡蛎10-30份、丹参10-30份、海藻10-30份、黄芪10-30份、蒲公英5-15份、醋乳香1-5份、醋没药1-5份、炒王不留行1-5份、青皮1-5份和人工麝香0.005-0.02份。
所述治疗乳腺增生的中药的最佳配方为:生牡蛎20份、丹参20份、海藻20份、黄芪20份、蒲公英10份、醋乳香3份、醋没药3份、炒王不留行3份、青皮3份、人工麝香0.01份。
同时,本发明的目的还在于提供一种用于治疗乳腺增生的中药的制备方法。
制备方法为:将生牡蛎、丹参、海藻、黄芪、蒲公英、醋乳香、醋没药、炒王不留行、青皮和人工麝香按重量比混合粉碎,制成散剂,装入瓶中,每瓶3克。
用法用量为:将药粉放入肚脐内,用食醋润湿成糊状,用海绵片压盖,再用胶布固定,即可。每次一瓶,根据病情轻重,每隔2-3日更换一次,8-12次为一个疗程。
本发明中各原料组分的功效为:
生牡蛎:含碳酸钙、磷酸钙及硫酸钙,并含铜、锌、铁、锰、锶、铬等微量元素及多种氨基酸,味咸而涩,性微凉,能软坚化痰,善消瘰,止呃逆,固精气;
丹参:味苦,性寒而缓,既能凉血活血,又能清热消痈,能祛瘀生新而不伤正,善调经水;
海藻:始载于《神农本草经》,“主瘿瘤气,颈下核,破散结气,痈肿癥瘕坚气,腹中上下鸣,下十二水肿”,本品在此处咸能润下,寒能泄热引水,可消瘿瘤结核之坚聚,使邪气从小便出;
黄芪:味甘,微温,主要含苷类、多糖、黄酮、氨基酸和微量元素。在本品中,可以起到健脾补中、升阳举陷、托毒生肌的作用;
蒲公英:苦、甘、寒,既能清解火热毒邪,又能泄降滞气,为消痈散结之佳品;
醋乳香:为橄榄科植物乳香树及其同属植物皮部渗出的树脂,辛香走窜,味苦通泄入血,能活血消痈,祛腐生肌;
醋没药:为橄榄科植物没药树及其同属植物皮部渗出的油胶树脂,功效于乳香相似,于乳香相须为用,乳香长于行气,没药长于活血化瘀;
炒王不留行:始载于《神农本草经》,能活血痛经,下乳消痈,利尿通淋;
青皮苦辛,辛散温通,苦泄下行,宜于肝郁气滞产生的胸胁肿胀,疝气疼痛,乳房肿痛,为理气要药;
人工麝香:辛温,外用可以活血散结,消肿止痛,在此处可引药内行,促进诸药发挥疗效。
本发明的优势在于:提供一种功效为疏肝理气、软坚散结、活血化瘀、益气生津、通络止痛的中药,用于治疗乳腺增生,同时可调整月经紊乱,促进乳房健美,并且此中药使用方便,价格便宜。
禁忌:经期不用,孕妇、功能性子宫出血及不明原因月经过多者禁用。
具体实施方式
实施例1:生牡蛎20份、丹参20份、海藻20份、黄芪20份、蒲公英10份、醋乳香3份、醋没药3份、炒王不留行3份、青皮3份、人工麝香0.01份。制备方法为:将各原料药物按重量比混合粉碎,制成散剂,装入瓶中,每瓶3克。
实施例2:生牡蛎10份、丹参10份、海藻10份、黄芪10份、蒲公英5份、醋乳香1份、醋没药1份、炒王不留行1份、青皮1份、人工麝香0.005份。制备方法同实施例1。
实施例3:生牡蛎30份、丹参30份、海藻30份、黄芪30份、蒲公英15份、醋乳香5份、醋没药5份、炒王不留行5份、青皮5份、人工麝香0.02份。制备方法同实施例1。
实施例4:生牡蛎15份、丹参15份、海藻15份、黄芪15份、蒲公英12份、醋乳香2份、醋没药2份、炒王不留行2份、青皮2份、人工麝香0.015份。制备方法同实施例1。
本发明的临床试验研究:
以上最佳配方经临床试验12例,治疗乳腺增生病,治愈2例(16.7%),显效7例(58.3%),有效2例(16.7%),无效1(8.3%)例,并有促进乳房健美功效,其治疗费用仅相当于口服药物的三分之一。
临床试验研究报告
1、病例选择标准
符合西医乳腺增生病的诊断标准或中医气滞血瘀症辩证标准,年龄在18-55岁,知情同意或志愿同意。
西医诊断标准有以下四种类型:
(1)乳痛症型:可为隐痛、钝痛或胀痛,或称“小叶增生”,多在月经前5-7天出现,月经来潮后缓解或消失;
(2)腺病型:是在小叶增生基础上发展起来的一种良性病变,乳房可触及硬韧的条梭状的增厚腺体及嵴样肿块;
(3)纤维化型:半数患者有不孕症,少数伴有月经前乳房胀痛,乳房可触及到不规则、界限不清,表面不光滑,质地坚韧的肿物,无触痛;
(4)囊肿病型:主要特点是导管上皮增生,导管极度扩张形成大小不等的囊肿,表现为乳房胀痛,与月经无关。
以上四种类型可单独存在,也可同时出现在一个小叶里。
辅助检查:X射线、超声检查、红外线扫描、CT与MRI、乳腺导管内镜、病理学检查等。
中医诊断标准:属于乳癖,及乳中结核,形如丸卵或垂坠,叫痛或不痛,皮色不变,其核随喜怒增长,系由思虑伤脾,恼怒伤肝,郁结而成,同时伴有月经量少、色暗或有血块,经行腹痛,舌质暗红,胎薄白,有瘀斑,脉弦或弦涩。
2、药物所含成分
生牡蛎、丹参、海藻、黄芪、蒲公英、醋乳香、醋没药、炒王不留行、青皮、人工麝香。
3、用药方法
用法用量为:将药粉放入肚脐内,用食醋润湿成糊状,用海绵片压盖,再用胶布固定,即可。每次一瓶,根据病情轻重,每隔2-3日更换一次,8-12次为一个疗程。
禁忌:经期不用,孕妇、功能性子宫出血及不明原因月经过多者禁用。
4、疗效的判断标准
治愈:乳房肿块、疼痛消失;
无效:乳房肿块、疼痛无改变,或乳房肿块长径缩小小于
5、病例治疗情况
12病例治疗情况表
结果:治愈率16.7%,显效率58.3%,有效率16.7%,无效率8.3%。
Claims (3)
1.一种治疗乳腺增生的中药,其特征在于,该中药的各组成重量份为:生牡蛎10-30份、丹参10-30份、海藻10-30份、黄芪10-30份、蒲公英5-15份、醋乳香1-5份、醋没药1-5份、炒王不留行1-5份、青皮1-5份和人工麝香0.005-0.02份。
2.根据权利要求1所述的中药,其特征在于,该中药的最佳配方为:生牡蛎20份、丹参20份、海藻20份、黄芪20份、蒲公英10份、醋乳香3份、醋没药3份、炒王不留行3份、青皮3份、人工麝香0.01份。
3.一种如权利要求1所述的中药的制备方法,其特征在于,制备方法为:将各种原料药物按重量比混合粉碎,制成散剂,装瓶即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210477093.8A CN102988543B (zh) | 2012-11-21 | 2012-11-21 | 一种治疗乳腺增生的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210477093.8A CN102988543B (zh) | 2012-11-21 | 2012-11-21 | 一种治疗乳腺增生的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102988543A CN102988543A (zh) | 2013-03-27 |
CN102988543B true CN102988543B (zh) | 2014-02-26 |
Family
ID=47917970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210477093.8A Active CN102988543B (zh) | 2012-11-21 | 2012-11-21 | 一种治疗乳腺增生的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102988543B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104645233A (zh) * | 2015-02-11 | 2015-05-27 | 张朋 | 一种治疗乳腺增生的中药制剂 |
CN104840904A (zh) * | 2015-06-12 | 2015-08-19 | 李兰珍 | 一种治疗乳腺增生的中药组合物 |
CN108030884A (zh) * | 2017-12-26 | 2018-05-15 | 支誉英 | 一种治疗乳腺病的中药及其制备方法 |
CN109172728A (zh) * | 2018-10-31 | 2019-01-11 | 田春生 | 一种治疗乳腺增生的药物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101708307A (zh) * | 2009-09-14 | 2010-05-19 | 北京勃然制药有限公司 | 一种用于治疗乳腺增生的药物及其制法 |
CN102451429A (zh) * | 2010-10-23 | 2012-05-16 | 郑州瑞龙制药股份有限公司 | 乳安片的制备方法 |
-
2012
- 2012-11-21 CN CN201210477093.8A patent/CN102988543B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102988543A (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940853B (zh) | 一种治疗乳腺增生疾病的脐膏 | |
CN104043049A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN102988543B (zh) | 一种治疗乳腺增生的中药及其制备方法 | |
CN101897882B (zh) | 一种治疗乳腺小叶增生及囊肿的药物 | |
CN101224290B (zh) | 治疗肝郁痰凝型乳癖的中药及其制备方法 | |
CN103223101A (zh) | 一种治疗甲状腺囊肿的中药 | |
CN1742979A (zh) | 一种治疗乳腺增生的中药 | |
CN101095784B (zh) | 一种妇科外用中药及制备方法 | |
CN104547736A (zh) | 一种治疗甲状腺肿的药物 | |
CN103251889A (zh) | 一种治疗乳汁不通的中药组合物 | |
CN102755515A (zh) | 治疗乳腺增生的中药汤剂 | |
CN101085303A (zh) | 一种内服治疗乳腺增生的中药组合物 | |
CN105362987A (zh) | 一种用于产后护理的中药制剂 | |
CN104173624A (zh) | 一种用于妇女暖宫的中药药膏及其制备方法 | |
CN104666397A (zh) | 一种治疗缺乳症的药物 | |
CN103735956A (zh) | 治疗宫颈癌的药物 | |
CN102205071B (zh) | 一种治疗甲状腺囊肿的中药组合物 | |
CN102240384B (zh) | 一种治疗痰瘀互结型癫痫的药物及其制备方法 | |
CN101406628B (zh) | 一种治疗乳腺病的丸药 | |
CN1285369C (zh) | 一种治疗妇科疾病的中药 | |
CN103735955B (zh) | 治疗肺癌的药物 | |
CN103463569A (zh) | 一种治疗十二指肠溃疡的中药制剂 | |
CN103585377B (zh) | 一种用于治疗乳癖的内服药物 | |
CN1736414A (zh) | 治疗妇女产后病及妇科疾病的中药丸剂 | |
CN103127352B (zh) | 一种治疗血瘀型月经不调的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |